| mRNA |
lapatinib |
UHNBreast |
pan-cancer |
AAC |
-0.28 |
0.4 |
| mRNA |
paclitaxel |
UHNBreast |
pan-cancer |
AAC |
-0.27 |
0.4 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
8e-07 |
| mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-06 |
| mRNA |
myriocin |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
0.04 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
3e-06 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
8e-06 |
| mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.05 |
| mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
2e-05 |
| mRNA |
PD-0325901 |
gCSI |
pan-cancer |
AAC |
-0.15 |
0.004 |